B-ENT
Review

Minimal outcome measurements in pediatric cochlear implant users: a consensus paper

1.

Department of Otorhinolaryngology, Head and Neck Surgery, Antwerp University Hospital, Antwerp, Belgium

2.

Experimental Laboratory of Translational Neurosciences and Dento-Otolaryngology, University of Antwerp, Faculty of Medicine and Health Sciences, Antwerp, Belgium

3.

OTICO Hearing Center (OHC), Cordoba, Argentina

4.

Ear Sciences Centre, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia

5.

Ear Science Institute Australia, Subiaco, Australia

6.

Department of Speech Langauge Pathology and Audiology, University of Pretoria, South Africa

7.

Deparment of Otolaryngology, Head & Neck Surgery, Medical School, The University of Western Australia, Perth, Australia

8.

Fiona Stanley Hospital, Perth, Australia

9.

Department of Otorhinolaryngology, Comprehensive Hearing Center, Plastic, Aesthetic and Reconstructive Head and Neck Surgery, University Hospital Würzburg, Germany

10.

Institute of Physiology and Pathology of Hearing, Kajetany, Poland

11.

ENT Super Specialty Institute and Research Center, Calicut, India

12.

Madras ENT Research Foundation (MERF), Chennai, India

B-ENT 2021; 17: 110-120
DOI: 10.5152/B-ENT.2021.20195
Read: 20 Downloads: 8 Published: 14 September 2021

The benefits of cochlear implantation in children with severe hearing impairments are widely known; however, there is no consensus regarding which minimal outcome measurements (MOMs) should be used to determine outcomes in this population with pediatric cochlear implant (CI). Therefore, the authors aim to propose a MOM test battery for pediatric CI recipients that can facilitate international multi-center research and collaboration. A pediatric MOM test battery was developed and agreed-upon by members of the HEARRING group across 30 expert clinics in the field of hearing implantation. The MOM test battery was chosen based on a literature search that focused on outcome measurements applied in clinical trials involving children with a hearing implant. Members of the HEARRING group were then asked to evaluate each of the pediatric MOM tests used. The final pediatric MOM test battery was defined for different chronological age categories (six weeks–18 years) at different suggested test intervals. The test battery includes objective hearing measurements, aided and unaided audiometry, speech perception tests in quiet and in noise, subjective hearing assessments, assessment of language development, and mental and motor development. This study presents a consensus on a MOM test battery for pediatric CI recipients that was agreed upon by members of the HEARRING group. This test battery should allow for international multi-center research to be able to extend and share evidence that will guide future clinical practice and research efforts in pediatric populations with CI.

Cite this article as: İnan S, Özer F, Erbek SS, Çaylaklı F, Ödemiş İ, Kurşun E. Minimal outcome measurements in pediatric cochlear implant users: a consensus paper. B-ENT 2021; 17(2): 110-20.

Files
EISSN 2684-4907